Pablo Marco-Rios

Granada, AN 18071, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.

Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.

Journal: Pharmaceutics

Published: December 15, 2021

Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors.

Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors.

Journal: Pharmaceutics

Published: July 30, 2021

The HCV genome domains 5BSL3.1 and 5BSL3.3 act as managers of translation.

The HCV genome domains 5BSL3.1 and 5BSL3.3 act as managers of translation.

Journal: Scientific reports

Published: September 10, 2018

Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors.

Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors.

Journal: Future medicinal chemistry

Published: July 26, 2018

Functional Information Stored in the Conserved Structural RNA Domains of Flavivirus Genomes.

Functional Information Stored in the Conserved Structural RNA Domains of Flavivirus Genomes.

Journal: Frontiers in microbiology

Published: January 23, 2017

The cis-acting replication element of the Hepatitis C virus genome recruits host factors that influence viral replication and translation.

The cis-acting replication element of the Hepatitis C virus genome recruits host factors that influence viral replication and translation.

Journal: Scientific reports

Published: November 09, 2015

Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1).

Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1).

Journal: Scientific reports

Published: October 29, 2015

RNA Aptamers as Molecular Tools to Study the Functionality of the Hepatitis C Virus CRE Region.

RNA Aptamers as Molecular Tools to Study the Functionality of the Hepatitis C Virus CRE Region.

Journal: Molecules (Basel, Switzerland)

Published: July 30, 2015

New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1.

New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1.

Journal: Future medicinal chemistry

Published: April 16, 2015

Discovery of a new binding site on human choline kinase α1: design, synthesis, crystallographic studies, and biological evaluation of asymmetrical bispyridinium derivatives.

Discovery of a new binding site on human choline kinase α1: design, synthesis, crystallographic studies, and biological evaluation of asymmetrical bispyridinium derivatives.

Journal: Journal of medicinal chemistry

Published: January 07, 2014

Choline kinase active site provides features for designing versatile inhibitors.

Choline kinase active site provides features for designing versatile inhibitors.

Journal: Current topics in medicinal chemistry

Published: December 20, 2013

New non-symmetrical choline kinase inhibitors.

New non-symmetrical choline kinase inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: June 21, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026